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Abstract 
 
Objective: To evaluate whether Attachment-Based Family Therapy (ABFT) is more 
effective than Enhanced Usual Care (EUC) for reducing suicidal ideation and depressive 
symptoms in adolescents. Method: Randomized controlled trial of suicidal adolescents between 
the ages of 12 and 17, identified in primary care and emergency departments. Of 341 adolescents 
screened, 66 (70% African American) entered the study for 3 months of treatment. Assessment 
occurred at baseline, six weeks, 12 weeks, and 24 weeks. ABFT consisted of individual and 
family meetings, and EUC consisted of a facilitated referral to other providers. All participants 
received weekly monitoring and access to a 24-hour crisis phone. Trajectory of change and 
clinical recovery were measured for suicidal ideation and depressive symptoms. Results: Using 
intent-to-treat, patients in ABFT demonstrated significantly greater rates of change on self-
reported suicidal ideation at post-treatment and benefits were maintained at follow-up, with a 
strong overall effect size (ES = .97). Between-group differences were similar on clinician ratings. 
Significantly more patients in ABFT met criteria for clinical recovery on suicidal ideation post-
treatment (87%; 95% CI, 74.6-99.6) than patients in EUC (51.7%; 95% CI, 32.4-54.32). Benefits 
were maintained at follow-up (ABFT, 70%; 95% CI, 52.6-87.4; EUC 34.6%; 95% CI, 15.6-
54.2), with a strong effect size (OR = 4.41). Patterns of depressive symptoms over time were 
similar, as were results for a subsample of adolescents with diagnosed depression. Conclusions: 
ABFT is more efficacious than EUC in reducing suicidal ideation and depressive symptoms in 
adolescents.  Additional research is warranted to confirm treatment efficacy and test the 
proposed mechanism of change.  
Keywords: adolescents, suicide, family therapy
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Introduction 
Suicide is the third leading cause of death in American adolescents, accounting for 1,371 
deaths of youth between the ages of 12 and 18 in 2005.1 In addition, every year nearly one 
million adolescents attempt suicide, leading to high emotional costs for families and financial 
costs for the health system.2  Unfortunately, no medication and few (less than 10) psychotherapy 
studies have focused on suicidal youth.3 Existing studies demonstrate only a slight reduction in 
suicide attempts or ideation, and experimental treatments have rarely been superior to treatment 
as usual.4-7 Cognitive Behavioral Therapy (CBT)8  and/or medication successfully reduced mild 
suicidal ideation in a depressed sample (TADS 12), but not in a more severely depressed and 
suicidal population .9 Overall, the efficacy of CBT and other forms of psychotherapy for suicidal 
youth has been mixed,3,10 and debate continues over whether medication exacerbates or reduces 
suicidal thinking.11 Clearly, research on alternative intervention approaches is warranted.  
 Family-based treatments for youth suicide are promising for a number of reasons. First, 
negative family functioning (e.g., high conflict, low cohesion, poor attachment, ineffective 
parenting, etc.) is a strong risk factor for youth suicide and depression.12 Family conflict may 
precede 20% of suicide deaths and 50% of non-fatal suicidal acts.13 Second, family conflict is 
frequently a negative moderator of treatment outcome.8,9,14 Third, family cohesion, emotional 
support, and appropriate supervision are protective factors in preventing suicide and  
depression.12    
Not surprisingly, several family intervention studies have shown promise for treating 
suicidal youth. Harrington et al., found routine care plus family intervention more effective at 
reducing suicidal ideation than routine care alone, but only for youth without major depression.15  
Huey et al. found Multisystemic Family Therapy more effective than hospitalization for 
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decreasing suicide attempts but not suicidal ideation, depressive affect, or hopelessness.16 Brent 
et al., found CBT and family therapy for depressed adolescents had significant reductions in 
suicidal ideation compared to supportive therapy post-treatment, but no difference at follow-up.14  
One promising intervention is ABFT, the first manualized family therapy specifically 
designed to target family processes associated with depression and suicide. ABFT aims to 
improve the family’s capacity for problem solving, affect regulation, and organization. This 
strengthens family cohesion, which can buffer against suicidal thinking, depression, and risk 
behaviors.12 In a study of ABFT for depressed adolescents, the treatment was found to 
significantly reduce suicidal ideation.17    
This study tested the efficacy of ABFT for reducing suicidal ideation in adolescents. This 
study was designed and powered specifically to examine reductions in suicidal ideation. While 
many adolescents may think about suicide sometimes, severe and persistent ideation is a serious 
risk factor for suicidal behavior.2,3,18 In addition, these youth present a worrisome challenge for 
parents, teachers, mental health and medical professionals, all of whom fear that ideation may 
lead to attempts. Unfortunately, ideators are often excluded from clinical trials because of the 
safety risks19 and no prevention or treatment studies target youth with severe ideation. Moreover, 
few studies have included a large sample of inner city, minority youth, a group whose risk for 
suicide has risen dramatically in the last decade.20 With funding from the Centers for Disease 
Control and Prevention, we aimed to test whether ABFT reduced suicidal ideation and 
depressive symptoms more than Enhanced Usual Care (EUC). Because treatment retention has 
been a challenge in treating suicidal youth,21,22 we also aimed to see if ABFT had better retention 
than treatment in the community.  
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Method 
Procedures 
 The research occurred in the Department of Psychiatry at the Children’s Hospital of 
Philadelphia (CHOP). Patients were recruited mainly from CHOP’s primary care offices and 
emergency room. During routine clinical interviews, patients identified as having suicidal 
thoughts were referred to the clinic social worker for an assessment. Adolescents who endorsed 
scores above 31 on the Suicidal Ideation Questionnaire (SIQ-JR)23 and above 20 on the Beck 
Depression Inventory (BDI-II)24 (i.e., moderate depression) were referred to our study. On a 
second screening, generally two days later (M = 2.21 days, SD = 1.34), if both suicide and 
depression scores remained above the cut-offs, patients were eligible for the study. For this high-
risk group, a longer waiting period was deemed unethical. Patients had to be between 12 and 17 
years old with a parent or guardian willing to participate.  
 Adolescents were not eligible if they 1) needed psychiatric hospitalization, 2) were 
recently discharged from a psychiatric hospital, 3) had current psychosis, or 4) had mental 
retardation or history of borderline intellectual functioning. Patients could remain on 
antidepressant medication if they had started it at least 12 weeks prior to randomization.  
 Eligible adolescents and parents signed a written, informed consent and were then 
randomized to either ABFT or EUC. Assessments were conducted at baseline, six weeks, 12 
weeks (post-treatment), and 24 weeks (follow-up, 12 weeks after treatment). All assessment staff 
had a B.A. in psychology and were trained, certified and supervised by the project coordinator. 
The study was approved by the IRB at CHOP.  
 We used an adaptive or "urn" randomization procedure, maintained by the statistician, 
with four stratification variables: age, gender, past suicide attempt, and family conflict. The 
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project coordinator was blind to the randomization sequence until the baseline assessment was 
complete. Given limited grant resources and clinical severity of the patients, blinding assessors 
to treatment assignment was not feasible.  
 Seven Ph.D. or MSW-level therapists provided ABFT (4 female, 3 male). Six were 
Caucasian and one was Asian-American. Each were trained, certified, and supervised by the first 
and fourth authors. Fidelity to treatment was monitored through weekly case discussion, 
videotape review, and live supervision.   
Treatments 
 Attachment-Based Family Therapy (ABFT). ABFT17,25 emerges from interpersonal 
theories that suggest depression and suicide can be precipitated, exacerbated, or buffered against 
by the quality of family relationships.26 Therefore, ABFT focuses on strengthening parent-
adolescent attachment bonds to create a protective and secure base for adolescent development. 
Therapy begins with a discussion of what prohibits the adolescent from turning to his or her 
parent(s) for help when contemplating suicide. Family barriers ranged from a) stress due to the 
adolescent’s depression, b) a history of negative interactions and communication, c) abuse, 
neglect, abandonment and or d) parental psychopathology. Even well-functioning families 
needed help effectively managing these suicidal crises.  
 Although ABFT therapists implement behavior focused and psychoeducational 
interventions, the model is primarily a process oriented, emotion focused treatment, guided by a 
semi-structured treatment protocol. Treatment is conceptualized as five specific tasks, each with 
a distinct process and goal. Treatment begins with the Relational Reframe Task, conducted with 
relevant family members, and aims to strengthen and or repair family relationships (as opposed 
to behavior management) as the primary initial treatment goal. Then the Adolescent Alliance 
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Task, with the adolescent alone, identifies core family conflicts linked to depression and prepares 
the adolescent to discuss these with his or her parents (1 to 2 sessions).   
 Next, the Parent Alliance Task with the parents alone aims to amplify parental love and 
empathy, and to teach emotionally focused parenting skills that will increase affective 
attunement (1 to 2 sessions). These sessions culminate in the Reattachment Task, where families 
come back together to discuss identified problems and practice new communication, problem 
solving, and affect regulation skills (3 to 4 sessions). As attachment relationships strengthen, 
therapists focus on the Competency Task. This task promotes adolescent autonomy (e.g., 
improving school functioning, increasing pleasant activities, etc.) while maintaining family 
connection. This ideal progression of tasks is modified as needed.    
 Enhanced Usual Care (EUC). EUC was a facilitated referral process with ongoing 
clinical monitoring. We found providers, set up initial appointments, and encouraged attendance.  
It was the treating therapist’s responsibility to engage and retain the adolescent in treatment. 
 Safety Monitoring. We monitored patient’s clinical status weekly using the SIQ-JR and 
BDI-II, administered either face-to-face (ABFT) or over the phone (EUC). Information regarding 
service utilization was gathered weekly. In addition, project staff were on call all the time in case 
of emergency.  
Outcome Measures 
 All outcome assessments were conducted face to face for all patients. The study had two 
declared primary outcomes: suicidal ideation and depressive symptoms. The self-report SIQ-JR23 
and assessor-administered Scale for Suicidal Ideation (SSI)27 were used to assess trajectory of 
change in suicidal ideation over time (total scores). For clinical recovery, we used the SIQ-JR 
<13 (based on a non clinical inner city, minority sample28 and SSI = 0). The SSI was 
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dichotomized because the data was not normally distributed, and to evaluate the treatment based 
on the absence of ideation.29  The self-report BDI-II was used to assess trajectory of change (total 
score) in depressive symptoms and clinical response (BDI-II < 9).14,24  
 Treatment retention was a secondary outcome, measured as number of sessions attended.  
For descriptive purposes and subgroup analyses, psychiatric diagnosis was determined using the 
clinician-administered, computerized Diagnostic Interview Schedule for Children (DISC).30 
Data Analysis 
Statistical Methods 
Tests of baseline differences in demographic and clinical characteristics were conducted 
using independent samples t-tests for continuous variables and Chi-square or Fisher exact tests of 
independence for categorical variables. Implementation of various Box-Cox transformations 
indicated a square-root transformation would correct the deviations in normality for the SIQ-JR 
and the BDI-II (both were negatively skewed). No substantial improvement in near normality 
was achieved for the SSI, so it was dichotomized.29  
The outcome analyses examined change across all four assessments. Hierarchical linear 
modeling (HLM) was used to investigate treatment differences using the intent-to-treat sample.31 
For the SIQ-JR and the SSI, the main efficacy analysis was determined to be piecewise, 
modeling the rate of change from baseline to 12 weeks (end of active treatment), and then again 
at 24 weeks (follow-up). For the BDI-II, the piecewise model ran first from baseline to 6 weeks 
(mid-treatment) and then to 24 weeks. For the binary outcomes, including clinical response, we 
implemented a hierarchical generalized linear model (HGLM), which accommodates the binary 
nature of the data, as well as the clustering within each subject. Effect size was measured using 
Cohen’s d for the continuous measures and odds ratios (OR) for the binary measures. The OR 
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corresponded to, on average, the number of times an event was more likely to occur for ABFT 
compared to EUC at each assessment.   
Nonparametric Wilcoxon Rank sum tests were used to compare number of sessions 
attended. Chi-square analyses were used to assess treatment retention at each assessment. The 
pattern-mixture model approach was used to assess whether missing data had a substantive 
influence on results. All analyses were conducted using SPSS Version 15 and SAS Version 
9.1.3. 
Statistical Power 
We originally estimated a required sample size of 120 patients for the longitudinal 
analysis of SIQ-JR. Given the time needed for creating a referral infrastructure with primary care 
and the short recruitment window (26 months), we did not achieve the targeted goals. The 
obtained sample sizes of 35 (ABFT) and 31 (EUC), with a 14.4% missing data rate at the 24 
week follow-up assessment, and an approximate intra-subject correlation of .40 (estimated value 
of 0.34 for the SIQ-JR scale), indicated the study power of 74.5%. Such power would yield a 
statistically significant result for an effect size of 0.60, power of 81.0% for an effect size of 0.65, 
and power of 86.4% for an effect size of 0.70.  
Results 
Enrollment Statistics 
Between March 2005 and May 2007, 341 adolescents were referred for the first screening 
(Figure 1). Of the 248 who were excluded, 188 did not meet study criteria, 36 became 
unreachable prior to the second screening, 14 refused study participation, six were hospitalized, 
and four were excluded for other reasons. Of the 93 who attended the second screening, 11 no 
longer met study criteria, eight were unreachable prior to consent, and five refused study 
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participation. Of the 69 who qualified based on the second screening, three reported psychotic 
features during intake and were excluded. Of the final sample, 50 participants (75%) were 
referred from primary care, and 16 (25%) were referred from emergency departments. 
Demographic, Clinical, and EUC Characteristics  
There were no differences on any demographic or clinical variables between the two 
treatment conditions (Table 1). The mean age was 15.1 years (SD = 1.5), 49 (74%) were African 
American, and 55 (83%) were female. Of the parents, 27 (41%) had an income under $30,000, 
17 (26%) were married and 46 (70%) had no more than a high school diploma. Thirty-one (47%) 
adolescents met criteria for a depressive disorder, 44 (67%) met criteria for any anxiety disorder, 
and 38 (57%) met criteria for an externalizing disorder (i.e., ADHD, oppositional, or conduct 
disorder). Forty-one (62%) participants reported having made a past suicide attempt, and nearly 
three quarters of those patients (30 of the 41 attempters) reported making multiple attempts. 
Twenty (30%) participants reported a history of suicide attempts in their families. Upon study 
entry, six patients were stable (more than 12 weeks) on antidepressant medication, three in each 
treatment condition.  
Of the patients in EUC, seven (23%) were referred to private practice, and 24 (77%) were 
referred to community mental health centers. Sixteen (52%) received individual therapy, six 
(19%) received group therapy, two (6%) received family therapy, one (3%) received case 
management, and six (19%) did not attend treatment. There were no differences in the 
completion rates of assessments between the two treatment groups at any of the time points. 
Implementation of the pattern-mixture approach indicated group comparisons were not biased 
due to completion status. 
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Trajectory of Change: Suicidal Ideation 
 On self-reported suicidal ideation (i.e., SIQ-JR), ABFT demonstrated a significantly 
greater rate of improvement during the treatment period (12 weeks) than EUC (F (1, 64) = 12.60, 
P = 0.001) (Figure 2; Table 2). No significant difference in rates of change was observed 
between treatments during the follow-up phase (F(1, 64) = 0.01, P < 0.91). During the treatment 
phase, the amount of change on the square-root of the SIQ-JR scale was -5.32 (se = 0.38) for 
ABFT and -3.35 (se = 0.40) for EUC. This corresponded to a significant difference of -1.97 (se = 
0.55) with a large effect size (d = .95) in favor of ABFT (t(64) = 3.55, P = 0.0007). The total 
change from baseline to follow-up on the square-root of the SIQ-JR for ABFT was -4.37 (se = 
0.40) and for EUC -2.34 (se = 0.43). This corresponded to a significant difference of 2.03 (se = 
0.59) with a large effect size (d = 0.97), in favor of ABFT (t(64) = -3.45, P = 0.001). Therefore, 
despite the slight increase of suicidal ideation for both groups during the follow-up phase, the 
large effect in favor of ABFT was maintained. 
 Regarding the trajectory of change of clinician-rated suicidality (SSI), ABFT 
demonstrated a significantly greater rate of change on the log-odds scale than EUC during the 
treatment phase (F(1,64)=6.32, P = 0.014). During the follow-up phase, there was no significant 
difference in rate of change between the two groups (F(1,64 ) = 0.20, P = 0.65). During the 
treatment phase, the amount of change on the log-odds SSI for ABFT was 2.51 (se = 0.51) and 
for EUC was 0.77 (se = 0.47). This corresponded to a significant difference of 1.74 (se = 0.69) 
with a medium to larger effect size (d = 0.62) in favor of ABFT (t(64) = 2.51, P = 0.014). The 
total change from baseline to follow-up on the log-odds SSI scale for ABFT was 3.21 (se = 0.61) 
and for EUC 1.14 (se = 0.53). This corresponded to a significant difference of 2.07 (se = 0.80) 
with a medium to large effect size (d = 0.64) in favor of ABFT (t(64) = 2.58, P = 0.012). 
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Therefore, while both groups improved after 12 weeks, ABFT continued to have a slightly higher 
rate of improvement, with a medium to large effect.  
Clinical Recovery: Suicidal Ideation  
For clinically meaningful change on the self-reported SIQ-JR (Table 3), ABFT had a 
significant effect at all time points and large effect sizes represented by the odds ratios. At six 
weeks, 69.7% of ABFT participants and 40.7% of EUC participants reported suicidal ideation in 
the normative range (OR = 3.35, 95% CI: 1.15-9.73; χ2(1) =5.07, P = 0.02). At 12 weeks, 87.1% 
of ABFT participants and 51.7% of EUC participants reported ideation in the normative range 
(OR = 6.30, 95% CI: 1.76-22.61, χ2(1) = 8.93, P = 0.003). At 24 weeks, 70.0% of ABFT 
participants and 34.6% of EUC participants reported ideation in the normative range (OR = 4.41, 
95% CI: 1.43-13.56; χ2(1) = 7.01, P = 0.008).  
 Clinical response on clinician-rated SSI demonstrated similar patterns as the SIQ-JR. At 
six weeks, 40.7% of ABFT participants and 33.3% of EUC participants reported no suicidal 
ideation in the past week (OR = 1.38, 95% CI: 0.44-4.32; χ2(1) = 0.30, P = 0.59). At 12 weeks, 
69.2% of the ABFT participants and 34.6% of the EUC participants reported no suicidal ideation 
in the past week (OR = 4.25, 95% CI: 1.33-13.56; χ2(1) = 6.24, P = 0.01). At 24 weeks, 82.1% 
of the ABFT participants and 46.2% of the EUC participants reported no suicidal ideation in the 
past week (OR = 5.37, 95% CI: 1.56-18.49; χ2(1) = 7.66, P = 0.006). Over the six months of the 
study, 11 patients made low lethality suicide attempts (ABFT= 4; EUC =7). These numbers are 
too small for statistical analysis.  
Depressive Symptoms 
Trajectory of change on self-reported depressive symptoms (BDI-II) showed a marginally 
significant differential rate of change during the first six weeks of treatment between the two 
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groups (F (1, 64) = 3.00, P = 0.09). From mid-treatment to follow-up, there was no significant 
difference in rate of change between the two groups (F(1, 64) = 0.33, P = 0.57). During the first 
six weeks, ABFT demonstrated an average reduction of 2.16 (se = 0.24) while EUC had an 
average reduction of 1.55 (se = 0.26) on the square root BDI-II. This corresponded to a near 
significant difference of 0.62 (se = 0.353) with a small to medium effect size (d = 0.37; t(64) = 
1.75, P = 0.08). For the total change from baseline to follow-up there was a non-significant 
difference of 0.36 (se = 0.51) with an effect size (d = 0.22) in favor of ABFT (t(64) = -0.72, P = 
0.48). 
For clinically meaningful change in depressive symptoms (i.e., BDI-II < 9), we found 
marginally significant effects and large effect sizes represented at all time points. At mid-
treatment, 34.4% of ABFT participants and 11.1% of EUC participants reported depression 
scores in the non-clinical range (OR = 4.19; 95% CI: 1.03-17.07; χ2(1) = 4.38 P = 0.04). At post-
treatment, 54.8% of ABFT participants and 31.0% of EUC participants reported non-clinical 
depression scores (OR = 2.70, 95% CI: 0.94-7.71; χ2(1) = 3.46, P = 0.06). At follow-up, 58.1% 
of ABFT participants and 38.5% of EUC participants reported non-clinical depression scores 
(OR = 2.21, 95% CI: 0.76-6.42; χ2(1) = 2.17, P = 0.14). 
Treatment Retention  
ABFT patients attended a significantly greater number of sessions (M = 9.71, SD = 5.26) 
than EUC patients (M = 2.87, SD = 3.3; Z = -4.74, P < .001). To determine if treatment rather 
than the number of sessions impacted the SIQ-JR scores, we explored the trajectory of change 
for the subsample of patients who received no more than six sessions in either treatment (ABFT 
= 9; EUC = 27). Similar to the findings in the full sample, analysis of the subsample 
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demonstrated that ABFT cases showed a marginally greater rate of change during the active 
treatment period compared to EUC (F(1, 34) = 2.84, P = 0.10).  
Subsample of Adolescents Diagnosed with Depression   
To facilitate comparison with other treatment studies, we looked at rates of change on 
SIQ-JR for those patients who met criteria for clinical depression during the past year (n = 35, 
53.0%; EUC = 19, 61.3%; ABFT = 16; 45.7%; χ2(1) = 1.60, P = 0.21). Similar to findings from 
the full data set, ABFT demonstrated a significantly greater rate of change than EUC for these 
depressed participants during the treatment phase (F (1, 33) = 6.16, P = 0.02). During the follow-
up phase, there was no significant difference in rate of change between the two groups (F(1, 33) 
= 0.10, P = 0.75). The total change, from baseline to follow-up was -4.35 (se = 0.66) for ABFT 
and -2.19 (se = 0.62) for EUC on the square-root SIQ-JR. This corresponded to a significant 
difference of 2.16 (se = 0.91) with an effect size (d = 1.00) in favor of ABFT (t(33) = -2.39, P = 
0.02). Therefore, the large effect on suicidal ideation in favor of ABFT for clinically depressed 
subjects is similar to the effect found for the full sample.   
Discussion 
 The findings from this study are promising. Compared to usual care in the community, 
youth treated with ABFT demonstrated significantly greater and more rapid reductions in 
suicidal ideation during the treatment. These differences persisted at follow-up with an overall 
large effect size. These findings are strengthened by the consistency across self-report and 
clinician ratings, and that findings were similar even if patients met criteria for a depressive 
diagnosis. ABFT was also associated with greater rates of clinical recovery. For this, we used the 
stringent criteria of scores similar to a non-clinical sample, below 13, rather than the SIQ-JR 
clinical cut off of 31. On both the SIQ-JR and the SSI, patients in ABFT at post-treatment and 
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follow-up, were at least 4 times more likely to show scores in recovery than patients in EUC. 
This is one of the few studies to demonstrate that a research treatment was more effective than 
treatment as usual for reducing suicidal ideation in adolescents.3  
 ABFT also demonstrated nearly significant reductions in depressive symptoms by mid-
treatment compared to EUC, with no difference at post-treatment and follow-up. Effect sizes, 
however, at all time points were very strong for ABFT, suggesting that a larger sample size may 
have produced statistical significance. In addition, long term differences between treatments for 
depression are uncommon,8,14 possibly due to the episodic nature of the disorder. Still, ABFT 
provided more rapid relief from depressive symptoms than community care, an important 
advantage when youth are at risk for suicide. These findings were supported by the measures of 
clinical recovery for depression. Compared to EUC, patients in ABFT were 3 times more likely 
to report BDI–II total scores in the non-clinical range at mid-treatment and 2.3 times more likely 
at follow-up.  
 The data on retention was particularly important. ABFT retained adolescents in treatment 
longer than usual care, even with the additional support and monitoring offered in EUC. These 
findings are meaningful given the difficulties of engaging suicidal youth in outpatient treatment. 
While better retention in research based therapy than in community therapy is not surprising, our 
retention rates were as good as or better than most clinical trials with suicidal, low income, 
minority youth.3, 7,21,22  This may be a factor of the highly structured parent engagement 
strategies of ABFT, but more research is needed to test that hypothesis.  
 Unfortunately, the low EUC retention rate also raises questions about the internal validity 
of the study. In other words, what is really causing the change? Differential outcomes may be a 
function of the treatment dose and not treatment type? Perhaps an equal dose of community care 
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would have achieved a similar outcome as ABFT. Alternatively, maybe outcome and retention 
effects were due to therapist differences. This study compared trained, research therapists 
receiving close supervision (ABFT) to a range of providers, with varied training backgrounds, 
working in a range of treatment settings. These two confounds (i.e., dose and therapist 
differences) plague most studies using TAU as a comparison group.32   
 Despite these limitations, many reasons support enthusiasm for the validity of the results. 
First, when comparing all patients that received a low dose of either treatment, patients in ABFT 
continued to show better outcomes. Second, if we compare post-treatment scores on the SIQ-JR 
across studies, where most samples start above a score of 31, ABFT (M=8) consistently does as 
well or better than other experimental treatments: 26 for Peer Nominated Support,5 24.5 for skill-
based treatment,7 11.8 for CBT plus fluoxetine, 14.4 for fluoxetine alone, 11.4 for CBT alone 
and 15 for placebo.8 While these points are encouraging, conclusive claims about the efficacy of 
ABFT for the treatment of suicidal youth will depend on a future study that can address the 
design issues outlined above.  
Other limitations should be considered. First, assessors were not blind to treatment 
assignment. Although not uncommon in studies of high-risk participants,29, 33 the consistency in 
findings across self-report and interviewer measures, and across multiple clinical domains, lends 
some confidence that assessor bias did not impact the results. Second, three-fourths of the sample 
was African American, and nearly half lived below the poverty level. Thus, our findings may not 
generalize to more affluent or culturally heterogeneous samples. Therefore, research on ABFT 
with more diverse populations is needed. Third, there is not data at this point to indicate when 
this treatment might be contraindicted (e.g., family conflict is too high or absent). Certainly, no 
treatment is perfect for all patients, though attempting to help any family through a suicidal crisis 
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seems clinically appropriate. Fourth, the relatively short follow-up (6 months post-
randomization) limits our understanding of long-term treatment benefits. Longer follow-up 
would better reflect treatment benefits. Finally, just to be clear, based on this study, we cannot 
claim that ABFT prevents suicidal behavior, only that it reduces suicidal ideation.     
An important goal of the National Strategy for Suicide Prevention is the development, 
testing, and dissemination of effective treatments for youth suicide.2 Family based interventions 
have shown efficacy in treating these youth, and ABFT in particular seems a promising treatment 
for reducing suicidal ideation and depressive symptoms. However, more empirical evidence on 
the efficacy and mechanisms of change for ABFT is warranted before conclusive claims can be 
made.  
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Table 1. Patient Characteristics  
 EUC 
(n = 31) 
ABFT 
(n = 35) 
P value 
Demographic Characteristics    
Age, mean (SD), y 15.29 (1.83) 15.11 (1.41) .66 
AA race, No. (%) 24 (77.4) 25 (71.4) .78 
Female sex, No. (%) 23 (74.2) 32 (91.4) .10 
Income, less than $30,000 yearly incomea, No. (%) 13 (44.8) 14 (43.8) 1.00 
Parent is high-school graduate, No. (%) 21 (84.0) 26 (78.8) .74 
Single-parent household, No. (%) 22 (73.33) 25 (73.53) .98 
Social Services involvement, No. (%) 13 (43.3) 12 (34.3) .61 
    
Current Psychiatric Diagnoses, No. (%)    
Major depressive episode 13 (41.9) 13 (37.1) .80 
Dysthymia 2 (6.5) 3 (8.6) 1.00 
Any anxiety 23 (74.2) 21 (60.0) .30 
Externalizing disorder (ADHD, ODD, CD)  15 (48%) 23 (65%) .16 
    
Clinical History, No. (%)    
Adolescent attempted suicide in the past 19 (61.3) 22 (62.9) 1.00 
Multiple attemptsc 12 (63.2) 18 (81.8) .29 
Past psychiatric hospitalization 7 (24.1) 7 (20.0) .77 
Taking antidepressant medicine 3 (10.3) 3 (8.6) 1.00 
Family history of suicide attempt 10 (34.3) 10 (30.3) .79 
a
 - Income: For the entire sample 27 (44.3%) had income under $30,000; 25 (41%) had income $30,000 - $70,000. 
c 
- Of those with history of attempt 
d
 - None were deaths of parents 
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Table 2. Rates of Change Estimates 
 PHASE 1 PHASE 2 
MEASURE ABFT 
estimate (se) 
EUC 
estimate (se) 
ABFT 
estimate (se) 
EUC 
estimate (se) 
SIQ-JR a -1.77 (0.13) -1.12 (0.13) 0.16 (0.06) 0.17 (0.07) 
SSI a 0.84 (0.17) 0.26 (0.16) 0.12 (0.09) 0.06 (0.08) 
BDI b -1.39 (0.18) -0.94 (0.19) -0.05 (0.05) 0.09 (0.05) 
SIQ-JR c -1.72 (0.21) -1.08 (0.19) 0.14 (0.09) 0.17 (0.09) 
a 
– PHASE 1 = change during active treatment; PHASE 2 = change during follow-up. 
b 
– PHASE 1 = change during the first six weeks of treatment; PHASE 2 = change from 6 weeks to follow-up. 
c 
– Only depressed participants.  PHASES defined as in a. 
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Table 3. Clinical Response by Treatment 
Clinical Response Rate % (CI) 
 ABFT (n=35) EUC (n=31) Odds Ratio P value 
SIQ-JR (<13)     
6 week 69.7=23/33 (53.1-86.2) 40.7=11/27(20.9-60.5) 3.35 0.02 
12 week  87.1=27/31 (74.6-99.6) 51.7=15/29 (32.4-71.1) 6.30 0.003 
24 week  70.0=21/30 (52.6-87.4) 34.6=9/26 (15.0-54.2) 4.41 0.008 
SSI (0 vs. 1)     
6 week  40.7=11/27 (20.9-60.5) 33.3=8/24 (13.0-53.7) 1.38 0.59 
12 week  69.2=18/26(50.2– 88.2) 34.6=9/26 (15.0-54.2) 4.25 0.013 
24 week  82.1=23/28 (67.0-97.3) 46.2=12/26(25.6– 66.7) 5.37 0.006 
BDI-II (≤  9)     
6 week  34.4=11/32 (17.0-51.8) 11.1=3/27 (1.6-23.8) 4.19 0.04 
12 week  54.8=17/31 (36.3-73.4) 31.0=9/29 (13.1-48.9) 2.70 0.06 
24 week  58.1=18/31 (39.7-76.8) 38.5=10/26 (18.4-58.5) 2.21 0.14 
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Table 4.  Means and Confidence Intervals  
Measure Assessment ABFT (n=35) EUC (n=31) 
Baseline 52.1 (47.5-56.7) 49.9 (44.9-54.9) 
6 week  15.0 (7.5-22.5) 22.2 (14.9-29.5) 
12 week  5.2 (1.6-8.8) 16.2 (10.1-22.2) 
SIQ 
24 week  10.4 (5.6-15.2) 23.0 (15.6-30.4) 
Baseline 14.2 (2.1-26.5) 19.4 (4.6-34.1) 
6 week  40.7 (20.9-60.5) 33.3 (13.0-53.7) 
12 week  69.2 (50.2 – 88.2) 34.6 (15.0-54.2) 
SSI 
24 week  82.1 (67.0-97.3) 46.2 (25.6 – 66.7) 
Baseline 33.0 (29.8-36.2) 33.0 (29.7-36.2) 
6 week  16.6 (11.5-21.8) 24.5 (18.9-30.1) 
12 week 12.6 (8.0-17.2) 18.5 (12.9-24.0) 
BDI 
24 week  12.4 (7.8-16.9) 16.2 (10.4-21.9) 
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Figure 1. Study Participants from Initial Screening Through Analysis 
 
248 Excluded
    188 Did not meet study criteriaa
      36 Unable to contact
      14 Refused consent
        6 Hospitalized
        4 Other
24  Excluded
     11 Did not meet study criteriab
      8  Unable to contact
      5  Refused consent
3 Excluded due to psychosis
35 Attachment Based Family Therapy 31 Enhanced Usual Care
32 Completed > 1 session 21 Completed > 1 session
24 Completed > 6 therapy sessions   6 Completed > 6 therapy sessions
22 Completed > 10 therapy sessions   2 Completed > 10 therapy sessions
33 Completed 6-week assessment 27 Completed 6-week assessment
31 Completed 12-week assessment 29 Completed 12-week assessment
31 Completed 24-week assessment 26 Completed 24-week assessment
35 Included in intent-to-treat analyses
341 Adolescents received initial screening
69 Underwent baseline assessment
66 Randomized
31 Included in intent-to-treat analyses
93 Adolescents received second screening
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Figure 2:  SIQ-JR. profile over time (square-root transformed) 
 
 
 
 
 
